229 related articles for article (PubMed ID: 21535996)
1. Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons.
Vogelzangs N; Beekman AT; Boelhouwer IG; Bandinelli S; Milaneschi Y; Ferrucci L; Penninx BW
J Clin Psychiatry; 2011 May; 72(5):598-604. PubMed ID: 21535996
[TBL] [Abstract][Full Text] [Related]
2. Hypercortisolemic depression is associated with the metabolic syndrome in late-life.
Vogelzangs N; Suthers K; Ferrucci L; Simonsick EM; Ble A; Schrager M; Bandinelli S; Lauretani F; Giannelli SV; Penninx BW
Psychoneuroendocrinology; 2007 Feb; 32(2):151-9. PubMed ID: 17224244
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenic obesity predicts nonremission of late-life depression.
Kokkeler KJE; van den Berg KS; Comijs HC; Oude Voshaar RC; Marijnissen RM
Int J Geriatr Psychiatry; 2019 Aug; 34(8):1226-1234. PubMed ID: 30990918
[TBL] [Abstract][Full Text] [Related]
4. Late-life depression symptom profiles are differentially associated with immunometabolic functioning.
Vogelzangs N; Comijs HC; Oude Voshaar RC; Stek ML; Penninx BW
Brain Behav Immun; 2014 Oct; 41():109-15. PubMed ID: 24838021
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study.
Milaneschi Y; Corsi AM; Penninx BW; Bandinelli S; Guralnik JM; Ferrucci L
Biol Psychiatry; 2009 Jun; 65(11):973-8. PubMed ID: 19111279
[TBL] [Abstract][Full Text] [Related]
6. Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study.
Sekita A; Arima H; Ninomiya T; Ohara T; Doi Y; Hirakawa Y; Fukuhara M; Hata J; Yonemoto K; Ga Y; Kitazono T; Kanba S; Kiyohara Y
BMC Public Health; 2013 Sep; 13():862. PubMed ID: 24044502
[TBL] [Abstract][Full Text] [Related]
7. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women.
Vogelzangs N; Kritchevsky SB; Beekman AT; Brenes GA; Newman AB; Satterfield S; Yaffe K; Harris TB; Penninx BW;
J Clin Psychiatry; 2010 Apr; 71(4):391-9. PubMed ID: 20021992
[TBL] [Abstract][Full Text] [Related]
8. Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study.
Crichton GE; Elias MF; Robbins MA
BMC Public Health; 2016 Jun; 16():502. PubMed ID: 27287001
[TBL] [Abstract][Full Text] [Related]
9. Metabolic dysregulation and late-life depression: a prospective study.
Marijnissen RM; Vogelzangs N; Mulder ME; van den Brink RH; Comijs HC; Oude Voshaar RC
Psychol Med; 2017 Apr; 47(6):1041-1052. PubMed ID: 27938429
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and incident depressive symptoms in young and middle-aged adults: A cohort study.
Jeon SW; Lim SW; Shin DW; Ryu S; Chang Y; Kim SY; Oh KS; Shin YC; Kim YH
J Affect Disord; 2019 Mar; 246():643-651. PubMed ID: 30611062
[TBL] [Abstract][Full Text] [Related]
11. Depression outcome among a biracial sample of depressed urban elders.
Cohen CI; Goh KH; Yaffee RA
Am J Geriatr Psychiatry; 2009 Nov; 17(11):943-52. PubMed ID: 19855198
[TBL] [Abstract][Full Text] [Related]
12. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing.
Hamer M; Batty GD; Kivimaki M
Mol Psychiatry; 2012 Sep; 17(9):940-5. PubMed ID: 22525487
[TBL] [Abstract][Full Text] [Related]
13. The relationship between plasma carotenoids and depressive symptoms in older persons.
Milaneschi Y; Bandinelli S; Penninx BW; Corsi AM; Lauretani F; Vazzana R; Semba RD; Guralnik JM; Ferrucci L
World J Biol Psychiatry; 2012 Dec; 13(8):588-98. PubMed ID: 21929378
[TBL] [Abstract][Full Text] [Related]
14. Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans.
Olvera RL; Williamson DE; Fisher-Hoch SP; Vatcheva KP; McCormick JB
J Clin Psychiatry; 2015 Oct; 76(10):e1300-5. PubMed ID: 26528653
[TBL] [Abstract][Full Text] [Related]
15. The role of metabolic syndrome in late-life depression over 6 years: The NESDO study.
Dekker IP; Marijnissen RM; Giltay EJ; van der Mast RC; Oude Voshaar RC; Rhebergen D; Rius Ottenheim N
J Affect Disord; 2019 Oct; 257():735-740. PubMed ID: 31386966
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users.
Vogelzangs N; Beekman AT; van Reedt Dortland AK; Schoevers RA; Giltay EJ; de Jonge P; Penninx BW
Neuropsychopharmacology; 2014 Jun; 39(7):1624-34. PubMed ID: 24442097
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition study.
Vogelzangs N; Beekman AT; Kritchevsky SB; Newman AB; Pahor M; Yaffe K; Rubin SM; Harris TB; Satterfield S; Simonsick EM; Penninx BW
J Gerontol A Biol Sci Med Sci; 2007 May; 62(5):563-9. PubMed ID: 17522363
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men.
Milaneschi Y; Shardell M; Corsi AM; Vazzana R; Bandinelli S; Guralnik JM; Ferrucci L
J Clin Endocrinol Metab; 2010 Jul; 95(7):3225-33. PubMed ID: 20444911
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome and Symptom Resolution in Depression: A 5-Year Follow-Up of Older Adults.
Virtanen M; Ferrie JE; Akbaraly T; Tabak A; Jokela M; Ebmeier KP; Singh-Manoux A; Kivimäki M
J Clin Psychiatry; 2017 Jan; 78(1):e1-e7. PubMed ID: 28129497
[TBL] [Abstract][Full Text] [Related]
20. Diet and physical activity in the association between depression and metabolic syndrome: Constances study.
Matta J; Hoertel N; Kesse-Guyot E; Plesz M; Wiernik E; Carette C; Czernichow S; Limosin F; Goldberg M; Zins M; Lemogne C
J Affect Disord; 2019 Feb; 244():25-32. PubMed ID: 30296663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
